254 related articles for article (PubMed ID: 37516418)
41. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
[TBL] [Abstract][Full Text] [Related]
42. Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells.
Wang Y; Liu Y; Lu J; Zhang P; Wang Y; Xu Y; Wang Z; Mao JH; Wei G
Biochem Biophys Res Commun; 2013 May; 434(2):352-6. PubMed ID: 23558291
[TBL] [Abstract][Full Text] [Related]
43. MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.
Xiang J; Hang JB; Che JM; Li HC
Int J Clin Exp Pathol; 2015; 8(8):9147-53. PubMed ID: 26464659
[TBL] [Abstract][Full Text] [Related]
44. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
[TBL] [Abstract][Full Text] [Related]
45. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
[TBL] [Abstract][Full Text] [Related]
46. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
47. Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer.
Fang L; Yang Z; Zhou J; Tung JY; Hsiao CD; Wang L; Deng Y; Wang P; Wang J; Lee MH
Mol Cancer Ther; 2015 Jun; 14(6):1476-87. PubMed ID: 25855785
[TBL] [Abstract][Full Text] [Related]
48. Novel Withanolides from
Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
[TBL] [Abstract][Full Text] [Related]
49. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
[TBL] [Abstract][Full Text] [Related]
50. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
51. FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation.
Richter KT; Kschonsak YT; Vodicska B; Hoffmann I
Cell Death Differ; 2020 Feb; 27(2):758-772. PubMed ID: 31285543
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma.
Kurashige J; Watanabe M; Iwatsuki M; Kinoshita K; Saito S; Hiyoshi Y; Kamohara H; Baba Y; Mimori K; Baba H
Br J Cancer; 2012 Jan; 106(1):182-8. PubMed ID: 22108521
[TBL] [Abstract][Full Text] [Related]
53. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
[TBL] [Abstract][Full Text] [Related]
54. Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
Wu WJ; Shi J; Hu G; Yu X; Lu H; Yang ML; Liu B; Wu ZX
Tumour Biol; 2016 May; 37(5):6045-51. PubMed ID: 26602384
[TBL] [Abstract][Full Text] [Related]
55. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.
Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S
Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148
[TBL] [Abstract][Full Text] [Related]
56. The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.
Zhang Q; Mady ASA; Ma Y; Ryan C; Lawrence TS; Nikolovska-Coleska Z; Sun Y; Morgan MA
Nucleic Acids Res; 2019 May; 47(8):4039-4053. PubMed ID: 30722038
[TBL] [Abstract][Full Text] [Related]
57. The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.
Reiterer V; Figueras-Puig C; Le Guerroue F; Confalonieri S; Vecchi M; Jalapothu D; Kanse SM; Deshaies RJ; Di Fiore PP; Behrends C; Farhan H
EMBO J; 2017 Feb; 36(3):260-273. PubMed ID: 28007894
[TBL] [Abstract][Full Text] [Related]
58. FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.
Zhan P; Wang Y; Zhao S; Liu C; Wang Y; Wen M; Mao JH; Wei G; Zhang P
Lab Invest; 2015 Sep; 95(9):995-1004. PubMed ID: 26097998
[TBL] [Abstract][Full Text] [Related]
59. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.
Li J; Guo Y; Liang X; Sun M; Wang G; De W; Wu W
J Cancer Res Clin Oncol; 2012 May; 138(5):763-74. PubMed ID: 22270966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
